Treatment Outcomes in Spinal Metastatic Disease With Indeterminate Stability.

Published online

Journal Article

STUDY DESIGN: Retrospective cohort study. OBJECTIVE: The purpose of this study was to compare outcomes between different treatment modalities for metastatic disease with indeterminate instability (Spinal Instability Neoplastic Score [SINS] 7-12). METHODS: We retrospectively reviewed neurologically intact patients treated for spinal metastatic disease with a SINS of 7 to 12. The cohort was stratified by treatment approach: external beam radiation therapy alone (EBRT), surgery + EBRT (S+E), and cement augmentation + EBRT (K+E). Kaplan-Meier analysis was used to assess differences in length of survival (LOS) and ability to ambulate at time of death. Multivariate analysis was performed to assess adjusted LOS and ability to ambulate at time of death. RESULTS: The cohort included 211 patients, S+E (n = 57), EBRT (n = 128), and K+E (n = 27). In the S+E group, the median LOS was 430 days, which was statistically longer than the median LOS for the EBRT group (121 days) and the K+E group (169 days). In the S+E group, 52 patients (91.2%) and in the K+E group 24 patients (92.3%) retained the ability to ambulate at their time of death compared to 99 patients (77.3%) of the EBRT patients (P = .01). The overall rate of revision treatment at the spinal level initially treated was 17.5%, S+E (15.8%), EBRT (20.3%), and K+E (7.7%). CONCLUSIONS: The length of survival, ability to maintain ambulatory ability, and revision treatment rates were all improved following surgical management and radiation therapy compared to radiation therapy alone. The authors' conclusion from these results are that patients with indeterminate spinal instability should be discussed in a multidisciplinary setting for the need of spinal stabilization in addition to radiation therapy.

Full Text

Duke Authors

Cited Authors

  • Dial, BL; Catanzano, AA; Esposito, V; Steele, J; Fletcher, A; Ryan, SP; Kirkpatrick, JP; Goodwin, CR; Torok, J; Hopkins, T; Mendoza-Lattes, S

Published Date

  • September 25, 2020

Published In

Start / End Page

  • 2192568220956605 -

PubMed ID

  • 32975442

Pubmed Central ID

  • 32975442

International Standard Serial Number (ISSN)

  • 2192-5682

Digital Object Identifier (DOI)

  • 10.1177/2192568220956605


  • eng

Conference Location

  • England